Have your say in shaping the future of NET care!

EURACAN is proud to support SCAN 2025 – the Survey of Challenges in Access to Diagnostics, Treatments and Care for NET Patients, launched by our partner INCA (International Neuroendocrine Cancer Alliance).
This global survey seeks input from both neuroendocrine tumour (NET) patients and healthcare professionals to identify gaps, challenges, and opportunities in access to care worldwide.🗓️ The survey is open until 30 November 2025

Available in 15 languages
👉 Access the questionnaires here
‍
‍By participating or sharing this initiative, you help generate robust evidence to inform healthcare policies, improve access to diagnostics and treatments, and strengthen the voice of the NET community globally.